Lavipharm S.A. LAVI.AT Stock
Lavipharm S.A. Price Chart
Lavipharm S.A. LAVI.AT Financial and Trading Overview
| Lavipharm S.A. stock price | 0.83 EUR |
| Previous Close | 0.57 EUR |
| Open | 0.58 EUR |
| Bid | 0.59 EUR x 340000 |
| Ask | 0.59 EUR x 100000 |
| Day's Range | 0.58 - 0.6 EUR |
| 52 Week Range | 0.34 - 1.44 EUR |
| Volume | 178.09K EUR |
| Avg. Volume | 231.04K EUR |
| Market Cap | 99.38M EUR |
| Beta (5Y Monthly) | 0.775478 |
| PE Ratio (TTM) | 14.8 |
| EPS (TTM) | -0.06 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | August 20, 2007 |
| 1y Target Est | N/A |
LAVI.AT Valuation Measures
| Enterprise Value | 37.28M EUR |
| Trailing P/E | 14.8 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.4022882 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 0.901 |
| Enterprise Value/EBITDA | 7.899 |
Trading Information
Lavipharm S.A. Stock Price History
| Beta (5Y Monthly) | 0.775478 |
| 52-Week Change | -49.19% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.44 EUR |
| 52 Week Low | 0.34 EUR |
| 50-Day Moving Average | 0.43 EUR |
| 200-Day Moving Average | 0.44 EUR |
LAVI.AT Share Statistics
| Avg. Volume (3 month) | 231.04K EUR |
| Avg. Daily Volume (10-Days) | 397.65K EUR |
| Shares Outstanding | 167.87M |
| Float | 7.15M |
| Short Ratio | N/A |
| % Held by Insiders | 67.47% |
| % Held by Institutions | 0.45% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:3 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | 2.48% |
| Operating Margin (ttm) | 8.39% |
| Gross Margin | 38.90% |
| EBITDA Margin | 11.40% |
Management Effectiveness
| Return on Assets (ttm) | 4.03% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 41.37M EUR |
| Revenue Per Share (ttm) | 2.43 EUR |
| Quarterly Revenue Growth (yoy) | 26.70% |
| Gross Profit (ttm) | 15.89M EUR |
| EBITDA | 4.72M EUR |
| Net Income Avi to Common (ttm) | 1.03M EUR |
| Diluted EPS (ttm) | 0.04 |
| Quarterly Earnings Growth (yoy) | -34.39% |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | 27.74M EUR |
| Total Debt/Equity (mrq) | 67.81 EUR |
| Current Ratio (mrq) | 1.146 |
| Book Value Per Share (mrq) | -0.586 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 4.59M EUR |
| Levered Free Cash Flow (ttm) | 3.88M EUR |
Profile of Lavipharm S.A.
| Country | Greece |
| State | N/A |
| City | Paiania |
| Address | 12, Agias Marinas Street |
| ZIP | 190 02 |
| Phone | 30 210 66 91 000 |
| Website | https://lavipharm.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 269 |
Lavipharm S.A. engages in the research, development, manufacturing, import, marketing, sale, and wholesaling of pharmaceutical, dermocosmetic, and healthcare products in Greece and internationally. The company offers pharmaceutical products for cardiology, chronic pain and oncology, central nervous system, respiratory system, gastrointestinal system, and urology; and over the counter (OTC) drugs, such as antiseptics, anagelsics, and anti-lice treatment products. It also provides a range of skincare products focused on health. The company was founded in 1911 and is based in Paiania, Greece.
Q&A For Lavipharm S.A. Stock
What is a current LAVI.AT stock price?
Lavipharm S.A. LAVI.AT stock price today per share is 0.83 EUR.
How to purchase Lavipharm S.A. stock?
You can buy LAVI.AT shares on the Athens exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Lavipharm S.A.?
The stock symbol or ticker of Lavipharm S.A. is LAVI.AT.
Which industry does the Lavipharm S.A. company belong to?
The Lavipharm S.A. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Lavipharm S.A. have in circulation?
The max supply of Lavipharm S.A. shares is 167.87M.
What is Lavipharm S.A. Price to Earnings Ratio (PE Ratio)?
Lavipharm S.A. PE Ratio is now.
What was Lavipharm S.A. earnings per share over the trailing 12 months (TTM)?
Lavipharm S.A. EPS is -0.06 EUR over the trailing 12 months.
Which sector does the Lavipharm S.A. company belong to?
The Lavipharm S.A. sector is Healthcare.